{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:44:08Z","timestamp":1773279848589,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11626-017-0145-2","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T17:48:27Z","timestamp":1493660907000},"page":"651-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro evaluation of combination of EGCG and Erlotinib with classical chemotherapeutics on JAR cells"],"prefix":"10.1007","volume":"53","author":[{"given":"El\u00e7in","family":"Telli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice","family":"Gen\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcug\u00fcl Altu\u011f","family":"Tasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sinan \u00d6zalp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tansu Koparal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"145_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-2407-10-84","volume":"10","author":"SV Bachawal","year":"2010","unstructured":"Bachawal SV, Wali VB, Sylvester PW (2010) Enhanced antiproliferative and apoptotic response to combined treatment of \u03b3-tocotrienol with erlotinib or gefitinib in mammary tumor cells. BMC Cancer 10:84","journal-title":"BMC Cancer"},{"key":"145_CR2","first-page":"479","volume":"40","author":"RG Bagley","year":"2012","unstructured":"Bagley RG, Ren Y, Kurtzberg L, Weber W, Bangari D, Brondyk W, Teicher BA (2012) Human choriocarcinomas: placental growth factor-dependent preclinical tumor models. Int J Oncol 40:479\u2013486","journal-title":"Int J Oncol"},{"key":"145_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-11-91","volume":"11","author":"A Cavazzoni","year":"2012","unstructured":"Cavazzoni A, Alfieri RR, Cretella D, Saccani F, Ampollini L, Galetti M, Galvani E (2012) Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines. Mol Cancer 11:1","journal-title":"Mol Cancer"},{"key":"145_CR4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejogrb.2008.12.009","volume":"143","author":"YX Chen","year":"2009","unstructured":"Chen YX, Lv WG, Chen HZ, Ye F, Xie X (2009) Methotrexate induces apoptosis of human choriocarcinoma cell line JAR via a mitochondrial pathway. European Journal of Obstetrics & Gynecology and Reproductive Biology 143:107\u2013111","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"key":"145_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1034\/j.1600-065X.2003.00048.x","volume":"193","author":"EM Creagh","year":"2003","unstructured":"Creagh EM, Conroy H, Martin SJ (2003) Caspase-activation pathways in apoptosis and immunity. Immunol Rev 193:10\u201321","journal-title":"Immunol Rev"},{"key":"145_CR6","first-page":"1","volume-title":"Choriocarcinoma. Reference Module in Biomedical Sciences","author":"K Dimas","year":"2015","unstructured":"Dimas K, Sakellaridis N (2015) Choriocarcinoma. Reference Module in Biomedical Sciences. Elsevier, Oxford, pp 1\u20133"},{"key":"145_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0143-4004(97)90067-9","volume":"18","author":"MS Filla","year":"1997","unstructured":"Filla MS, Kaul KL (1997) Relative expression of epidermal growth factor receptor in placental cytotrophoblasts and choriocarcinoma cell lines. Placenta 18:17\u201327","journal-title":"Placenta"},{"key":"145_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2005.07.001","volume":"160","author":"G Fotakis","year":"2006","unstructured":"Fotakis G, Timbrell JA (2006) In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 160:171\u2013177","journal-title":"Toxicol Lett"},{"key":"145_CR9","first-page":"1147","volume":"142","author":"V F\u00fcl\u00f6p","year":"2001","unstructured":"F\u00fcl\u00f6p V, Vegh G, Doszpod J (2001) The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study). Orv Hetil 142:1147\u20131154","journal-title":"Orv Hetil"},{"key":"145_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ygyno.2012.06.014","volume":"127","author":"SN Han","year":"2012","unstructured":"Han SN, Amant F, Leunen K, Devi UK, Neven P, Berteloot P, Vergote I (2012) Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate\u2013etoposide. Gynecol Oncol 127:47\u201350","journal-title":"Gynecol Oncol"},{"key":"145_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jphs.2015.04.003","volume":"128","author":"F Hu","year":"2015","unstructured":"Hu F, Wei F, Wang Y, Wu B, Fang Y, Xiong B (2015) EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. J Pharmacol Sci 128:27\u201334","journal-title":"J Pharmacol Sci"},{"key":"145_CR12","first-page":"177","volume":"4","author":"M John","year":"1997","unstructured":"John M, Rajalekshmy T, Nair B, Augustine J, Schultz G, Nair K, Balaram P (1997) Expression of epidermal growth factor and its receptor in gestational trophoblastic diseases. Oncol Rep 4:177\u2013182","journal-title":"Oncol Rep"},{"key":"145_CR13","first-page":"76","volume":"47","author":"PJ Kim","year":"2004","unstructured":"Kim PJ, Lim HC, Kim DW, Lee YS (2004) In vitro interaction of Taxol with other antitumor drugs in the established choriocarcinoma cell lines. Korean Journal of Obstetrics and Gynecology 47:76\u201382","journal-title":"Korean Journal of Obstetrics and Gynecology"},{"key":"145_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2013.07.027","volume":"339","author":"MJ Kim","year":"2013","unstructured":"Kim MJ, Yun HS, Hong EH, Lee SJ, Baek JH, Lee CW, Hwang SG (2013) Depletion of end-binding protein 1 (EB1) promotes apoptosis of human non-small-cell lung cancer cells via reactive oxygen species and Bax-mediated mitochondrial dysfunction. Cancer Lett 339:15\u201324","journal-title":"Cancer Lett"},{"key":"145_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bcp.2014.01.010","volume":"88","author":"JC Ko","year":"2014","unstructured":"Ko JC, Chiu HC, Syu JJ, Jian YJ, Chen CY, Jian YT, Lin YW (2014) Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cells. Biochem Pharmacol 88:119\u2013127","journal-title":"Biochem Pharmacol"},{"key":"145_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02976458","volume":"23","author":"ANT Kong","year":"2000","unstructured":"Kong ANT, Yu R, Chen C, Mandlekar S, Primiano T (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 23:1\u201316","journal-title":"Arch Pharm Res"},{"key":"145_CR17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bcp.2009.08.021","volume":"79","author":"YH Kuang","year":"2010","unstructured":"Kuang YH, Shen T, Chen X, Sodani K, Hopper-Borge E, Tiwari AK, Chen ZS (2010) Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance. Biochem Pharmacol 79:154\u2013161","journal-title":"Biochem Pharmacol"},{"key":"145_CR18","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.clnu.2013.03.008","volume":"32","author":"E Lecumberri","year":"2013","unstructured":"Lecumberri E, Dupertuis YM, Miralbell R, Pichard C (2013) Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 32:894\u2013903","journal-title":"Clin Nutr"},{"key":"145_CR19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13206-010-4305-7","volume":"4","author":"J Lee","year":"2010","unstructured":"Lee J, Kim YJ, Ryu JC (2010) Study on teratogenic effects of methotrexate; alteration of gene expression pattern in human placenta choriocarcinoma (JEG-3) cells. BioChip Journal 4:189\u2013196","journal-title":"BioChip Journal"},{"key":"145_CR20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ygyno.2006.05.011","volume":"103","author":"CA Lok","year":"2006","unstructured":"Lok CA, Ansink AC, Grootfaam D, Velden J, Verheijen RH, Marianne J (2006) Treatment and prognosis of post term choriocarcinoma in the Netherlands. Gynecol Oncol 103:698\u2013702","journal-title":"Gynecol Oncol"},{"key":"145_CR21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.94940","volume":"4","author":"T Mahmood","year":"2012","unstructured":"Mahmood T, Yang PC (2012) Western blot: technique, theory, and trouble shooting. N Am J Med Sci 4:429","journal-title":"N Am J Med Sci"},{"key":"145_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejphar.2009.04.020","volume":"613","author":"AJ Mazur","year":"2009","unstructured":"Mazur AJ, Nowak D, Mannherz HG, Malicka-B\u0142aszkiewicz M (2009) Methotrexate induces apoptosis in CaSki and NRK cells and influences the organization of their actin cytoskeleton. Eur J Pharmacol 613:24\u201333","journal-title":"Eur J Pharmacol"},{"key":"145_CR23","first-page":"2770","volume":"7","author":"M Moroni","year":"2001","unstructured":"Moroni M, Veronese S, Schiavo R, Carminati O, Sorensen BS, Gambacorta M, Siena S (2001) Epidermal growth factor receptor expression and activation in nonseminomatous germ cell tumors. Clin Cancer Res 7:2770\u20132775","journal-title":"Clin Cancer Res"},{"key":"145_CR24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","volume":"13","author":"R Rosell","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R, Vergnenegre A, Massuti B, Felip E, Palmero R, Garcia Gomez R, Pallares C, Sanchez JM, Porta R, Cobo M, Garrido P, Longo F, Moran T, Insa A, De Marinis F, Corre PR (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. The lancet oncology 13:239\u2013246","journal-title":"The lancet oncology"},{"key":"145_CR25","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2013.11.002","volume":"79","author":"R Roskoski","year":"2014","unstructured":"Roskoski R (2014) The ErbB\/HER family of protein-tyrosine kinases and cancer. Pharmacol Res 79:34\u201374","journal-title":"Pharmacol Res"},{"key":"145_CR26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trim.2015.03.001","volume":"32","author":"J Savikko","year":"2015","unstructured":"Savikko J, Rintala JM, Rintala S, Koskinen P (2015) Epidermal growth factor receptor inhibition by erlotinib prevents vascular smooth muscle cell and monocyte\u2013macrophage function in vitro. Transpl Immunol 32:175\u2013178","journal-title":"Transpl Immunol"},{"key":"145_CR27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.yexcr.2015.04.010","volume":"334","author":"Y Shen","year":"2015","unstructured":"Shen Y, Yang J, Zhao J, Xiao C, Xu C, Xiang Y (2015) The switch from ER stress-induced apoptosis to autophagy via ROS-mediated JNK\/p62 signals: a survival mechanism in methotrexate-resistant choriocarcinoma cells. Exp Cell Res 334:207\u2013218","journal-title":"Exp Cell Res"},{"key":"145_CR28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.abb.2004.03.028","volume":"425","author":"D Shim","year":"2004","unstructured":"Shim D, Kang HY, Jeon BW, Kang SS, Chang SI, Kim HY (2004) Protein kinase B inhibits apoptosis induced by actinomycin D in ECV304 cells through phosphorylation of caspase 8. Arch Biochem Biophys 425:214\u2013220","journal-title":"Arch Biochem Biophys"},{"key":"145_CR29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","volume":"82","author":"BN Singh","year":"2011","unstructured":"Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807\u20131821","journal-title":"Biochem Pharmacol"},{"key":"145_CR30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.taap.2013.07.013","volume":"272","author":"A Sobhakumari","year":"2013","unstructured":"Sobhakumari A, Schickling BM, Love-Homan L, Raeburn A, Fletcher EV, Case AJ, Simons AL (2013) NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells. Toxicol Appl Pharmacol 272:736\u2013745","journal-title":"Toxicol Appl Pharmacol"},{"key":"145_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bpobgyn.2011.11.009","volume":"26","author":"KY Tse","year":"2012","unstructured":"Tse KY, Ngan HY (2012) Gestational trophoblastic disease. Best Practice & Research Clinical Obstetrics & Gynaecology 26:357\u2013370","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"key":"145_CR32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/gyno.2000.5777","volume":"77","author":"ZS Tuncer","year":"2000","unstructured":"Tuncer ZS, Vegh GL, Fulop V, Genest DR, Mok SC, Berkowitz RS (2000) Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor. Gynecol Oncol 77:389\u2013393","journal-title":"Gynecol Oncol"},{"key":"145_CR33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1525-1438.2006.00606.x","volume":"16","author":"T Turan","year":"2006","unstructured":"Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, Kose MF (2006) Results with EMA\/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy in gestational trophoblastic neoplasia. Int J Gynecol Cancer 16:1432\u20131438","journal-title":"Int J Gynecol Cancer"},{"key":"145_CR34","first-page":"555","volume":"22","author":"Y Xiang","year":"2000","unstructured":"Xiang Y, Li Z, Cui Q, Yang X, Song H (2000) Expression of epidermal growth factor receptor in gestational trophoblastic tumours. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 22:555\u2013557","journal-title":"Acta Academiae Medicinae Sinicae"},{"issue":"1","key":"145_CR35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cellsig.2011.08.015","volume":"24","author":"X Zhou","year":"2012","unstructured":"Zhou X, Agazie YM (2012) The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR. Cell Signal 24(1):140\u2013150","journal-title":"Cell Signal"},{"key":"145_CR36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fitote.2014.08.007","volume":"99","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Wang S, Lin F, Li Q, Xu A (2014) The therapeutic effects of EGCG on vitiligo. Fitoterapia 99:243\u2013251","journal-title":"Fitoterapia"}],"container-title":["In Vitro Cellular & Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11626-017-0145-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-017-0145-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-017-0145-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T16:21:59Z","timestamp":1500308519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11626-017-0145-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1007\/s11626-017-0145-2","relation":{},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,1]]}}}